HOME >> MEDICINE >> NEWS
Refined stem cell therapy helps paralyzed rats recover

A therapy that combines differentiated stem cells with myelin inhibitors and a motor axon tropic factor helped paralyzed rats restore functional motor units and gain some physical recovery. "This is the first report, to our knowledge, of the anatomical and functional replacement of a motor neuron circuit within the adult, mammalian host," the authors report. The study is in the July issue of Annals of Neurology, a journal published by John Wiley & Sons. The article is also available online via Wiley Interscience (www.interscience.wiley.com/journal/ana).

Scientists' ability to differentiate stem cells toward specific mature cell lineages is assisting in the study of diseases and the development of new treatments. Embryonic stem cells can be induced to create normal pathways for the generation of spinal motor neurons, and this activity can be encouraged by certain pharmacologic agents. The results could help victims of paralysis regain motor function.

Based on this hypothesis, researchers led by Douglas Kerr, M.D., Ph.D. of Johns Hopkins University School of Medicine explored different strategies to restore motor function in paralyzed rats. They used agents to inhibit myelin-mediated axon repulsion and others to provide attractive cues within peripheral nerves. They hoped to stimulate the formation of functional muscular units.

They began by inducing embryonic stem cells from rats to differentiate into motor neurons. They then injected the neurons near the spinal cords of rats that had been paralyzed by a virus. To explore treatment strategies, they divided the rats into 8 groups. Some received neurons that had been treated to potentially increase their survival and their ability to extend axons. Some groups received injections of Rolipram and dibutyrl cAMP to potentially neutralize the inhibitory effects of myelin on axon outgrowth. And some groups received a motor axon tropic factor,
'"/>

Contact: Amy Molnar
amolnar@wiley.com
John Wiley & Sons, Inc.
21-Jun-2006


Page: 1 2

Related medicine news :

1. Chemotherapy with bevacizumab increases risk of blood clots in arteries
2. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
3. Stroke in nonvascular atrial fibrillation -- anti-coagulants better than anti-platelet therapy
4. Hormone therapy offers new hope for ovarian cancer patients
5. Borderline personality disorder shows improvements with intensive psychotherapy
6. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
7. Chemotherapy may enhance the effectiveness of brain tumor vaccines
8. Brain-boosting pill alleviates post-chemotherapy fogginess
9. Adding radioimmunotherapy to chemo may help patients with lymphoma
10. Pre-operative chemotherapy does not increase survival rates for nonsmall cell lung cancer
11. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab ... to be the preferred physical therapy provider for Derby City CrossFit, effective immediately. ... City CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists will ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report ... score performance for the 2015-16 school year across Wisconsin’s public schools, charter schools, ... highlights important patterns in student test score performance, the report’s limited analyses fail ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... targets, they rely on contracted partners to help with process innovation in drug ... combined drug formulation experience along with state-of-the-art analytical equipment in support of their ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the ... or chronic problems, I focus on preventative care with all my patients to alleviate possible ... questions, always feel free to contact my office and my trained staff will assist you ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
Breaking Medicine Technology:
Cached News: